Summary by Moomoo AI
On June 24, 2024, CSPC Pharma Limited submitted a new disclosure report, disclosing its shareholding changes. According to the report, CSPC Pharma conducted share buy-back activities from June 21 to June 24, 2024. On June 21, the company bought back 10,000,000 shares, accounting for 0.084% of the issued shares, at a buy-back price per share of HKD 6.3613. On June 24, CSPC Pharma bought back another 7,900,000 shares, accounting for 0.066% of issued shares, at a buy-back price per share of HKD 6.2648. In total, the company bought back 7,900,000 shares on June 24 at a price range of HKD 6.39 to HKD 6.21, involving a total amount of HKD 49,491,640. After the buy-back, the total number of issued shares of the company remained at 11,896,091,732 shares, with no new shares issued or stock resale or transfer. In addition, CSPC Pharma confirmed that the total number of shares the company can buy back under the buy-back authorization obtained on May 28, 2024, is 1,189,609,173 shares. Currently, 17,900,000 shares have been bought back, accounting for 0.15% of the buy-back authorization.
